- Telehealth Visits
- Insurance plan information
Line Jacques, MD, MS
Neurosurgery • Pediatric Neurosurgery- Telehealth Visits
- Insurance plan information
Line Jacques, MD, MS
Neurosurgery • Pediatric Neurosurgery- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurological Surgery, American Board of Neurological Surgery
Fellowship
- Neurosurgery, Louisiana State University (LSU) - Shreveport GME
Residency
- Neurosurgery, University of Montreal Hospital Saint-Luc
Internship
- General Surgery, St. Luc Hospital
Degree
- MD, Universite de Montreal
Academic title
- Clinical Professor
My expertise
Specialties
- Neurosurgery
- Pediatric Neurosurgery
Conditions
- Peripheral Nerve Tumors
Locations
My research
Publications
Showing 1-6 of 92 reviews
- June 22, 20265 out of 5 Stars
Compassionate and intelligent care
- June 21, 20261 out of 5 Stars
I explained to the doctor the app on my phone wasn't transcribing (I'm deaf). She never sent a message summarizing what she said that I asked for.
- June 16, 20265 out of 5 Stars
Dr Jacques is wonderful. She listens and explains everything very clearly. I trust her with my care and treatment. She's very caring and cpassionate
- June 13, 20265 out of 5 Stars
Dr. Jacques is an excellent provider. She listens carefully to your concerns and needs.
- June 9, 20265 out of 5 Stars
Dr Jacques is profession, friendly, and fabulous!
- May 27, 20265 out of 5 Stars
Dr Jacques was kind and patient with me. I had found out about my cancer diagnosis that morning and I was very unsettled and having difficulty even communicating. She was very understanding.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.